http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Akram Al-Ibraheem,Dhuha Ali Al‑Adhami,Ahmed Saad Abdlkadir,Nabeela Al‑Hajaj,Rami Ghanem,Ramiz Abu‑Hijlih,Samer Salah 대한핵의학회 2023 핵의학 분자영상 Vol.57 No.4
Molecular imaging is an important tool for evaluating patients with prostate cancer, including those with hybrid histopathology. Although rare, mixed small neuroendocrine tumor/acinar adenocarcinoma exhibit aggressive behavior that necessitatesoptimal therapy. Molecular imaging has been implemented previously to assess radioligand therapy eligibility in such cases. Interestingly, the uptake of radiotracers targeting prostate-specific membrane antigen (PSMA) and somatostatin receptor maybe reduced and can potentially lead to false negative readings in certain tumor types with hybrid features. Therefore, physiciansshould be aware of different kinds of disparities when assessing these tumor types with the aforementioned modalities.